2nd Quarter - Report

AMERICAN CLINICAL LABORATORY ASSN for AMERICAN CLINICAL LABORATORY ASSN

Firm
Client
Income
—
Expenses
$200,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Health reform law implementation issues including application of medical device tax to laboratory tests and laboraty fee schedule cuts; the oversight of laboratory-developed tests, HR 3207, the Modernizing Laboratory Test Standards for Patients Act; Budget Control Act of 2011(PL 112-225); in-office ancillary services exception to Stark law; HR 5651, Food and Drug Administration Reform Act, S. 3187, Food and Drug Administration Safety and Innovation Act, HR 6118, the Taking Essential Steps for Testing Act

LobbyistCovered position, as disclosed
JASON DUBOIS Vice President, Government Affairs
JO ANNE GLISSON Senior Vice President
JENNIFER BULLARD MADSEN Vice President, Policy and Medical Affairs
SCOTT VAN BUREN MCGOOHAN Director, Regulatory and Reimbursement Affairs
ALAN MERTZ President
FRANCESCA FIERRO O'REILLY Vice President, Government Affairs

Contacted: Centers For Medicare and Medicaid Services (CMS); White House Office; SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Treasury, Dept of; Health & Human Services, Dept of (HHS)

Bills named: H.R. 5651 (112th), H.R. 3207 (112th), H.R. 6118 (112th), S. 3187 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.